Predicting initiation and progression of chronic kidney disease: Developing renal risk scores (Q36592131)

15 August 2017

1 reference

title

Predicting initiation and progression of chronic kidney disease: Developing renal risk scores (English)

1 reference

chronic renal insufficiency

15 August 2017

1 reference

Taal MW

1

1 reference

15 August 2017

Brenner BM

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

13 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

70

1 reference

15 August 2017

1694-1705

1 reference

15 August 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5001794

15 August 2017

0 references

cites work

Screening for proteinuria in US adults: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Classifying kidney problems: can we avoid framing risks as diseases?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Long-term effects of reduced renal mass in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Multi-hit nature of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk factors for progressive chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Long-Term Epidemiologic Prediction of Coronary Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Longitudinal studies on the rate of decline in renal function with age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk of developing end-stage renal disease in a cohort of mass screening.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predictors of new-onset kidney disease in a community-based population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

End-stage renal disease in African-American and white men. 16-year MRFIT findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Cumulative risk for developing end-stage renal disease in the US population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The need and demand for renal replacement therapy in ethnic minorities in England

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Epidemic renal disease of unknown etiology in the Zuni Indians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Excess incidence of treatment of end-stage renal disease in Mexican Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

An epidemic of renal failure among Australian Aboriginals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Population-based screening for family history of end-stage renal disease among incident dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Family members of patients treated for ESRD have high rates of undetected kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Low birth weight, nephron number, and kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Glomerular number and size in autopsy kidneys: the relationship to birth weight

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Fetal programming and adult health

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

A new dimension to the Barker hypothesis: Low birthweight and susceptibility to renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Long-term follow-up after partial removal of a solitary kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Diabetic Glomerulopathy Following Unilateral Nephrectomy in the Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

'Hypertension' and 'microalbuminuria': the bell tolls for thee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Renal function and hemodynamic study in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

After all those fat years: renal consequences of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The effects of weight loss on renal function in patients with severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Association between body mass index and CKD in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Body mass index and risk for end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The metabolic syndrome and chronic kidney disease in U.S. adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

A central body fat distribution is related to renal function impairment, even in lean subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Protein-induced glomerular hyperfiltration: role of hormonal factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Renal hemodynamic changes in humans. Response to protein loading in normal and diseased kidneys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Glomerular and tubular function in glycogen storage disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Cellular responses to protein overload: key event in renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Clinical prognostic factors in biopsy-proven benign nephrosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Progression of kidney disease in type 2 diabetes - beyond blood pressure control: an observational study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Renal abnormalities in sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Sickle cell disease and the kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Association of anemia with outcomes in men with moderate and severe chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effects of hypertension and dyslipidemia on the decline in renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Serum uric acid and renal prognosis in patients with IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Mild hyperuricemia induces glomerular hypertension in normal rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Hormonal and cytokine effects of uric acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The renal risks of smoking: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk of end-stage renal disease associated with alcohol consumption.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Lifestyle risk factors and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Moderate alcohol intake and renal function decline in women: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Lifestyle factors, obesity and the risk of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Recreational drug use: a neglected risk factor for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Analgesic use and chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Lifetime nonnarcotic analgesic use and decline in renal function in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Analgesic use and chronic renal failure: a critical review of the epidemiologic literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Blood lead and chronic kidney disease in the general United States population: results from NHANES III.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

The profile of cardiac patients with renal artery stenosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001794

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001794

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference